Vivere Lifesciences Acquisition

Vivere Lifesciences Acquisition Corp., a newly incorporated exempted company under the laws of the Cayman Islands, is a special purpose acquisition company (SPAC) established for the purpose of completing a SPAC business combination transaction. In identifying SPAC merger targets, the company will primarily focus on companies in the global healthcare industry with a China perspective, particularly those engaged in biotechnology, diagnostics, medical professional equipment, novel platform technologies, healthcare-related technologies, synthetic biology, and CXO fields, demonstrating innovative characteristics and capable of realizing synergistic value through our ecosystem.